Investment Bank Drops Coverage of Helicos BioSciences | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Leerink Swann has dropped coverage of Helicos BioSciences, citing both long-term and short-term challenges the firm faces in gaining market share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.